Target Audience: This activity is designed for Dentists, Nurses, Pharmacists, Pharmacy Technicians, PAs, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators, and the Healthcare Team. This activity is accredited for Physicians, Nurses, Pharmacists, PAs, Social Workers, and the Healthcare Team. 

Module Description: There are not enough treatment providers to meet the needs of our patients with OUD. Telemedicine can increase access to patients who require ongoing substance use disorder treatment. However, there are numerous regulatory, logistical and other clinical questions, which are also rapidly changing, around implementing telemedicine delivery of medication treatment for OUD (tele-MOUD). In this presentation, we will: present evidence on tele-MOUD but focus most of the discussion on clinical considerations in using implementing telemedicine to deliver quality buprenorphine treatment.

Educational Objectives:

• Recognize key changes in federal regulations and guidance since the onset of  COVID-19 and what they mean for telemedicine for OUD treatment.
• Describe the potential ways that telemedicine for OUD treatment can address current treatment needs while also discussing important clinical considerations in using telemedicine for OUD treatment, including specific patients’ characteristics, clinic practices, and local resources to consider.
• Review information on key regulatory/legal requirements and technology considerations important to use of telemedicine for OUD treatment.

Continuing Education information:

Accreditation Statement

In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Nurse Practitioners

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 CNE credits.

Pharmacists

This activity has been approved for 1 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers: JA4008192-0000-24-015-H01-P (pharmacy).

PAs

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 4/10/2027. PAs should only claim credit commensurate with the extent of their participation.

Social Workers

As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credits.

Other Health Professionals and Other Learners

Participants will receive a certificate stating this program is designated for 1 AMA PRA Category 1 Credits™. This credit is accepted by the AANP and the AAPA.

All Learners

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.